Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories
Tickers AMZN BLK DIS EADSY
Tags General GOOGL DIS
From Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
Tickers BIIB ESALF ESALY
Tags General BIIB FDA
From Benzinga
Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades'
Tickers ESALY IEF MDT MRK
Tags Market News Anastasia Amoroso Markets
From Benzinga
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
Tickers ESALY MRK PFE
Tags Market News General MRK
From Benzinga
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
Tickers BIIB ESALF ESALY LLY
Tags General Expert Ideas Benzinga
From Benzinga
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
Tickers BIIB ESALF ESALY LLY
Tags News Large Cap Alzheimer’s
From Benzinga
Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
Tickers ESALF ESALY MRK
Tags MRK General Market News
From Benzinga
Tesla Manufactured 4,000 Model Ys In One Week, UBS Prepping For Massive Layoffs, McDonald's Temporary Shuttering Of US Offices: Today's Top Stories
Tickers ATVI BIIB BOXD CS
Tags Benzinga SBUX Biotech
From Benzinga
National Institute on Aging Aims Building $300M Alzheimer's Research Database
Tickers BIIB ESALF ESALY
Tags BIIB Market News News
From Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Biotech ESALF Benzinga
From Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
Tickers BIIB ESALY HRMY INCY
Tags MRK BIIB NASDAQ:BIIB,NYSE:INSP,NASDAQ:INCY,NYSE:LLY,NYSE:MCK,NYSE:MRK,NASDAQ:HRMY,OTCMKTS:ESALY
From InvestorPlace
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
Tickers BIIB ESALF ESALY LLY
Tags BIIB Market News Alzheimer’s
From Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
Tickers BIIB ESALF ESALY
Tags Large Cap News Health Care
From Benzinga
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
Tickers BIIB ESALF ESALY
Tags General BIIB FDA
From Benzinga
Why Anavex Life Sciences Stock Bolted Higher in January
Tickers AVXL BIIB ESALY
Tags BIIB Recent Press Releases Market News
From Motley Fool
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
Tickers APLS BIIB CYTK EBS
Tags CYTK GILD News
From Benzinga
Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?
Tickers BIIB ESALY LLY
Tags LLY ESALY Market News
From Motley Fool
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
Tickers BIIB ESALY
Tags BIIB Recent Press Releases Market News
From Motley Fool
This Monumental Breakthrough Could Turn the World Upside Down -- and Make Some Investors Filthy Rich
Tickers ABBV BIIB ESALY GOOG
Tags BIIB Market News UNH
From Motley Fool
Should You Buy Biogen Stock After Its Latest Alzheimer's Disease Drug Approval?
Tickers BIIB ESALY
Tags Market News Recent Press Releases ESALY
From Motley Fool
Barron's Top Weekend Stock Picks: Tesla, Snowflake, Delta And Why Warren Buffett's Berkshire Hathaway May Be In For Big Tax Bill
Tickers BIIB BRK-A BRK-B DAL
Tags ZM Benzinga ESALY
From Benzinga
FDA approves treatment for people with mild forms of Alzheimer’s
Tickers BIIB ESALY SPX
Tags BIIB SPX ESALY
From MarketWatch
FDA Approves Biogen's Second Alzheimer's Treatment Under Accelerated Pathway
Tickers BIIB ESALF ESALY
Tags BIIB why it's moving Market News
From Benzinga
Lecanemab Alert: What Would Alzheimer’s Drug Approval Mean for Biogen (BIIB) Stock?
Tickers BIIB ESALY
Tags ESALY Market News BIIB
From InvestorPlace
1 Stock Defying the Downturn to Buy, and 1 to Avoid
Tickers AZN BIIB ESALY
Tags AZN BIIB Recent Press Releases
From Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Tickers BGNE BIIB CDTX CHRS
Tags Small Cap FDA Approval Biopharma
From Benzinga
1 Green Flag and 1 Red Flag for Biogen
Tickers BIIB ESALY
Tags Recent Press Releases Market News ESALY
From Motley Fool
Biogen's Alzheimer's Antibody Might Have A Third Death Associated With
Tickers BIIB ESALF ESALY
Tags News Large Cap Briefs
From Benzinga
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
Tickers CPRX ESALF ESALY
Tags News Trading Ideas ESALF
From Benzinga
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
Tickers BIIB BNTX ESALY INCY
Tags Stocks to Buy PFE ESALY
From InvestorPlace
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.